Click a keyword to view all the abstracts on this site tagged with that keyword.
- bone density and osteoporosis
- bone density and radiography
- bone density and radiology
- Bone density and rheumatoid arthritis (RA)
- bone density and risk
- bone density and sarcopenia
- Bone density and spondylarthropathy
- bone density and steroids
- Bone density and systemic lupus erythematosus (SLE)
- Bone density and uric acid
- bone disease
- bone disease and genetic disorders
- bone disease and imaging techniques
- bone disease and osteoclastogenesis
- bone disease and rheumatoid arthritis (RA)
- bone disease and treatment
- bone disease and x-ray
- Bone erosion
- Bone marrow
- bone marrow and interferons
- bone marrow and macrophage activation syndrome
- bone marrow and osteoarthritis
- Bone marrow and osteoclasts
- Bone marrow and scleroderma
- bone marrow and systemic lupus erythematosus (SLE)
- bone marrow lesions
- bone marrow lesions and osteoarthritis
- bone marrow lesions and rheumatoid arthritis (RA)
- bone metabolism
- Bone metabolism and rheumatoid arthritis (RA)
- Bone metabolism and spondylarthritis
- bone remodeling
- bone remodeling and prostaglandins
- bone remodeling and rheumatoid arthritis (RA)
- bone remodeling and spondylarthropathy
- Bone turnover markers
- bone turnover markers and inflammation
- bone turnover markers and modified stoke ankylosing spondylitis spinal score (MSASSS)
- Bone turnover markers and systemic lupus erythematosus (SLE)
- Bortezomib
- Bortezomib and SLE
- botulinum toxin and pain management
- botulinum toxin and treatment
- Bowel
- BR3
- Brain Biopsy
- BTK
- business
- business and rheumatoid arthritis (RA)
- C Reactive Protein
- C Reactive Protein and synovitis
- C-reactive protein (CRP)
- C-reactive protein (CRP) and Disease Activity
- C-reactive protein (CRP) and renal disease
- C-reactive protein (CRP) and rheumatoid arthritis (RA)
- C-reactive protein (CRP) and scleroderma
- C1q
- cadherin-11
- Cadherins
- calcinosis
- calcinosis and dermatomyositis
- Calcinosis and juvenile dermatomyositis
- Calcinosis and scleroderma
- Calcinosis and treatment
- Calcitonin
- Calcium
- Calcium and denosumab
- calcium and rheumatoid arthritis (RA)
- calcium and signal transduction
- Calcium pyrophosphate dihydrate (CPPD)
- Calcium pyrophosphate dihydrate (CPPD) and diagnosis
- Calcium pyrophosphate dihydrate (CPPD) and pseudogout
- Calcium pyrophosphate dihydrate (CPPD) and rheumatoid arthritis (RA)
- Calcium pyrophosphate dihydrate (CPPD) and synovial fluid
- calcium pyrophosphate dihydrate (CPPD) and ultrasound
- Calgranulin
- canakinumab
- Canakinumab and caregivers
- canakinumab and corticosteroids
- canakinumab and familial Mediterranean fever
- canakinumab and fever
- canakinumab and interleukins (IL)
- canakinumab and juvenile idiopathic arthritis (JIA)
- canakinumab and monoclonal antibodies
- Canakinumab and safety
- canakinumab and treatment
- Cancer
- cancer and cancer treatments
- Cancer and cutaneous lupus erythematosus
- cancer and histopathologic
- cancer and human papillomavirus (HPV)
- Cancer and inflammatory arthritis
- cancer and malignancy
- Cancer and myositis
- Cancer and polymyositis/dermatomyositis (PM/DM)
- Cancer and psoriatic arthritis
- cancer and registry
- cancer and rheumatoid arthritis (RA)
- cancer and scleroderma
- cancer and systemic lupus erythematosus (SLE)
- Cancer treatments
- cancer treatments and immune response
- cancer treatments and inflammatory arthritis
- cancer treatments and morbidity and mortality
- Cancer treatments and osteoporosis
- cancer treatments and rheumatologic disease
- Cancer treatments and rituximab
- cancer treatments and systemic sclerosis
- cannabinoid
- Capillaroscopy
- capillaroscopy and chemokines
- capillaroscopy and nailfold capillaroscopy
- capillaroscopy and scleroderma
- capillaroscopy and systemic sclerosis
- capillary microscopy
- capillary microscopy and connective tissue diseases
- carboxypeptidase B and rheumatoid arthritis (RA)
- Cardiovascular and rheumatoid arthritis
- Cardiovascular disease
- cardiovascular disease and cholesterol
- cardiovascular disease and comorbidity
- Cardiovascular disease and cutaneous lupus erythematosus
- cardiovascular disease and depression
- cardiovascular disease and diabetes
- Cardiovascular disease and diffuse idiopathic skeletal hyperostosis (DISH)
- cardiovascular disease and endothelial cells
- cardiovascular disease and epidemiologic methods
- cardiovascular disease and extraarticular manifestations
- cardiovascular disease and fibrosis
- cardiovascular disease and genetic disorders
- cardiovascular disease and genetics
- Cardiovascular disease and giant cell arteritis
- Cardiovascular disease and glucocorticoids
- cardiovascular disease and gout
- Cardiovascular disease and hydroxychloroquine
- cardiovascular disease and immunoglobulin (IG)
- cardiovascular disease and inflammatory arthritis
- Cardiovascular disease and juvenile arthritis
- cardiovascular disease and juvenile dermatomyositis
- Cardiovascular disease and juvenile idiopathic arthritis (JIA)
- cardiovascular disease and lipids
- cardiovascular disease and longitudinal studies
- cardiovascular disease and meta-analysis
- cardiovascular disease and methotrexate (MTX)
- cardiovascular disease and morbidity and mortality
- cardiovascular disease and mycophenolate mofetil
- Cardiovascular disease and myositis
- cardiovascular disease and nonsteroidal antiinflammatory drugs (NSAIDs)
- Cardiovascular disease and nutrition
- cardiovascular disease and obesity
- Cardiovascular disease and osteoporosis
- cardiovascular disease and pediatric rheumatology
- cardiovascular disease and physical activity
- cardiovascular disease and primary care
- Cardiovascular disease and psoriatic arthritis
- cardiovascular disease and race/ethnicity
- cardiovascular disease and reactive arthritis
- Cardiovascular disease and rheumatic disease
- cardiovascular disease and rheumatoid arthritis
- Cardiovascular disease and rheumatoid arthritis (RA)
- cardiovascular disease and risk
- cardiovascular disease and risk assessment
- cardiovascular disease and rituximab
- cardiovascular disease and statins
- cardiovascular disease and systemic lupus erythematosus (SLE)
- Cardiovascular disease and systemic sclerosis
- cardiovascular disease and thrombosis
- Cardiovascular disease and tocilizumab
- cardiovascular disease and tofacitinib
- cardiovascular disease and uric acid
- Career
- career and fellowship programs
- Career and mentor
- caregivers
- caregivers and quality of life
- caregivers and rheumatic disease
- Carpal tunnel syndrome
- Carpal tunnel syndrome and corticosteroids
- cartilage
- cartilage and chondrocytes
- cartilage and exercise
- cartilage and imaging techniques
- cartilage and magnetic resonance imaging (MRI)
- cartilage and methotrexate (MTX)
- cartilage and mouse model
- cartilage and osteoarthritis
- cartilage and race/ethnicity
- cartilage and rheumatoid arthritis
- cartilage and rheumatoid arthritis (RA)
- Cartilage and stem cells
- cartilage and synovitis
- cartilage and transforming growth factor
- Case Report
- Case-based
- Castleman's disease
- Castleman's disease and IgG4 Related Disease
- Catecholamines
- catecholamines and cytokines
- Cathepsin
- cathepsin k inhibitor